Masimo Corp  (MASI)
Other Ticker:  
Price: $127.1800 $0.18 0.142%
Day's High: $128.745 Week Perf: 2.14 %
Day's Low: $ 125.99 30 Day Perf: -6.58 %
Volume (M): 706 52 Wk High: $ 169.58
Volume (M$): $ 89,827 52 Wk Avg: $120.35
Open: $127.00 52 Wk Low: $75.22

 Market Capitalization (Millions $) 6,893
 Shares Outstanding (Millions) 54
 Employees 8,815
 Revenues (TTM) (Millions $) 1,975
 Net Income (TTM) (Millions $) 79
 Cash Flow (TTM) (Millions $) -17
 Capital Exp. (TTM) (Millions $) 88

Masimo Corp
Masimo Corporation is a publicly traded medical technology company that was founded in 1989 by Joe Kiani. Its headquarters is located in Irvine, California, and it is considered one of the leading innovators in the healthcare industry. Masimo has a global presence and operates in over 130 countries.

Masimo's primary focus is on developing and manufacturing innovative solutions to improve patient outcomes and reduce healthcare costs. The company produces a range of products that include patient monitoring systems, pulse oximeters, sensors, and other medical devices. Masimo's products are used in hospitals, clinics, home healthcare settings, emergency medical services, military and veterinary settings.

One of Masimo's most famous inventions is the Signal Extraction Technology (SET), which is a patented technology that revolutionized pulse oximetry. Pulse oximetry is a non-invasive method of measuring a person's oxygen saturation levels, and SET technology significantly improves the accuracy and reliability of this measurement, preventing misdiagnosis and unnecessary interventions.

Masimo has received several prestigious awards and recognition for its innovative products and services. In 2021, Masimo was ranked as one of the World's Most Innovative Companies by Forbes, an accolade that the company has received multiple times in the past.

The company's growth has been fueled by its continuous investments in research and development. Masimo has a robust pipeline of new products and services in development that are designed to improve patient outcomes and quality of care while reducing healthcare delivery costs.

Furthermore, Masimo is also committed to sustainability and social responsibility. The company's sustainability program includes initiatives to reduce its carbon footprint, increase recycling, and minimize waste. It also supports various charitable organizations globally, providing life-saving medical equipment, supplies, and medicine to people in need.

Overall, Masimo Corporation is considered a trailblazer in the medical technology industry, with an exceptional track record of developing and delivering innovative solutions that revolutionize the healthcare industry. Its commitment to sustainability and social responsibility makes it a standout business in its field.

   Company Address: 52 Discovery Irvine, 92618 CA
   Company Phone Number: 297-7000   Stock Exchange / Ticker: NASDAQ MASI


Stock Performances by Major Competitors

5 Days Decrease / Increase
SONO   -1.28%    
VZIO   -0.38%    
• View Complete Report

Business Update

Augmenting Clinical Research: Medable and Masimo Team Up to Bring Cutting-Edge Wea...

Published Wed, May 29 2024 12:38 PM UTC

Medable and Masimo Partner to Bring Best-in-Class Wearable Devices to Clinical Research, Capturing Rich Subjective and DataPALO ALTO, Calif. - Medable Inc., the leading technology provider for modern clinical trials, has announced a partnership with industry leader Masimo (NASDAQ: MASI) to introduce the use of high-quality medical-grade wearable devices in clinical research...


Masimo Corporation Under Investigation for Potential Securities Misconduct

Published Sun, May 19 2024 10:00 PM UTC

In recent news, Rosen Law Firm, a renowned global investor rights law firm, has initiated an investigation into potential securities claims on behalf of shareholders of Masimo Corporation (NASDAQ: MASI). The investigation stems from allegations that Masimo may have provided materially misleading information to the investing public, consequently jeopardizing shareholders' int...

Masimo Corp

2 Masimo Corp Faces Financial Challenges as Revenue and Profitability Decline in First Quarter of 2024

As a financial reporter for the CSIMarket.com, I have been closely following the recent financial results of Masimo Corporation, a leading global provider of noninvasive monitoring technologies and audio products. The company announced its first quarter results for 2024, revealing a concerning decline in both revenue and profitability compared to the previous year.
In the first quarter of 2024, Masimo reported a decrease in income by -10.26% to $0.35 per share and a decline in revenue by -12.766% year on year. This drop resulted in revenue of $492.70 million, down from $564.80 million in the same period a year before. Additionally, profit plummeted by -44.76% from $0.63 per share, and net profits fell to $18.900 million from $21.300 million in the corresponding period a year earlier.

Business Update

Masimo Corporation Considers Separation of Consumer Business Amidst Revenue Decline and Enhanced Profitability

Published Fri, Mar 22 2024 8:05 PM UTC

Masimo Corporation, a leading global provider of noninvasive monitoring technologies and audio products, is contemplating the separation of its consumer business. The company's Board of Directors has authorized management to assess the proposed separation, which is expected to encompass consumer audio and health products like the Stork baby monitor and Freedom smartwatch. Th...

Masimo Corp

Masimo Corporation Faces Revenue Decline and Earnings Drop in Fiscal Fourth Quarter of 2023

In the fiscal fourth quarter of 2023, Masimo Corporation (NASDAQ: MASI), a prominent player in the Medical Equipment & Supplies sector, experienced a decline in revenue and bottom-line. The company reported a decrease of 18.55% in income, resulting in earnings per share (EPS) falling to $0.63. Revenue also took a hit, dropping by 11.064% year on year, with figures amounting to $548.70 million compared to $616.96 million in the same period of the previous year.
Revenue Performance:
While Masimo Corporation faced a decrease in revenue, the Medical Equipment & Supplies sector as a whole witnessed a rise in the fourth quarter of 2023. In comparison to previous periods, the company demonstrated an impressive 14.599% revenue growth from $478.8 million and a 216.82% growth in EPS from $0.20 per share.


Masimo's Segments
• View Complete Report
  Company Estimates  
  Revenue Outlook
Masimo does not provide revenue guidance.

Earnings Outlook
Masimo Corp does not provide earnings estimates.

Geographic Revenue Dispersion


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com